Baihan Wang

50. PHARMACOGENETICS TESTING TO OPTIMISE PRESCRIBING IN PSYCHOSIS

Background Several antipsychotics, and most antidepressants, have pharmacogenetic clinical guidelines as well as FDA/MHRA/EMA approved labels providing recommendations on drug selection or dose adjustments based on genetic data. However, implementation of pharmacogenetics testing...

Proteomics in cardiology: research and practice

Despite recent advances in prevention and treatment, cardiovascular disease (CVD) remains a leading cause of premature death and disability globally, with a rising burden in many low- and middle-income countries. Several modifiable determinants of CVD are well-established (eg, sm...